References
- Fayad L, Kantarjian H, O'Brien S, Seong D, Albitar M, Keating M, et al. Emergence of new clonal abnormalities following interferon-alpha induced complete cytogenetic response in patients with chronic myeloid leukemia: report of three cases. Leukemia 1997; 11: 767–771
- Bacher U, Hochhaus A, Berger U, Hiddemann W, Hehlmann R, Haferlach T, et al. Clonal aberrations in Philadelphia chromosome negative hematopoiesis in patients with chronic myeloid leukemia treated with imatinib or interferon A. Leukemia 2005; 19: 460–463
- Andersen M K, Pedersen-Bjergaard J, Kjeldsen L, Dufva I H, Brondum-Nielsen K. Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8. Leukemia 2002; 16: 1390–1393
- O'Dwyer M E, Gatter K M, Loriaux M, Druker B J, Olson S B, Magenis R E, et al. Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukaemia during major cytogenetic responses induced by imatinib mesylate. Leukemia 2003; 17: 481–487
- Athanasiadou A, Stavroyianni N, Saloum R, Asteriou O, Anagnostopoulos A, Fassas A. Novel chromosomal aberrations in Philadelphia negative cells of chronic myelogenous leukemia patients on imatinib: report of three cases. Leukemia 2004; 18: 1029–1031
- Lin Y, Bruyere H, Horsman D, Pantzar T, Barnett M, Hogge D, et al. Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive factors. Cancer Genet Cytogenet 2006; 170: 16–23
- Fabarius A, Haferlach C, Móller M C, Erben P, Lahaye T, Giehl M, et al. Dynamics of cytogenetic aberrations in Philadelphia chromosome positive and negative hematopoiesis during dasatinib therapy of chronic myeloid leukemia patients after imatinib failure. Haematologica 2007; 92: 834–837
- Kovitz C, Kantarjian H, Garcia-Manero G, Abruzzo L V, Cortes J. Myelodysplastic syndromes and acute leukemia developing after imatinib mesylate therapy for chronic myeloid leukemia. Blood 2006; 108: 2811–2813
- Jabbour E, Kantarjian H M, Abruzzo L V, O'Brien S, Garcia-Manero G, Verstovsek S, et al. Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Blood 2007; 110: 2991–2995